Justin B Echouffo-Tcheugui1, Stephen J Greene1, Lampros Papadimitriou1, Faiez Zannad1, Clyde W Yancy1, Mihai Gheorghiade1, Javed Butler2. 1. From the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA (J.B.E.-T.); Center for Cardiovascular Innovation, Department of Medicine (S.J.G., M.G.) and Department of Cardiology (C.W.Y.), Northwestern University Feinberg School of Medicine, Chicago, IL; Division of Cardiology, Department of Medicine, Stony Brook University, NY (L.P., J.B.); and CHU Nancy, Department of Cardiology, Institute of Lorraine Heart and Blood Vessels, Nancy, France (F.Z.). 2. From the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA (J.B.E.-T.); Center for Cardiovascular Innovation, Department of Medicine (S.J.G., M.G.) and Department of Cardiology (C.W.Y.), Northwestern University Feinberg School of Medicine, Chicago, IL; Division of Cardiology, Department of Medicine, Stony Brook University, NY (L.P., J.B.); and CHU Nancy, Department of Cardiology, Institute of Lorraine Heart and Blood Vessels, Nancy, France (F.Z.). javed.butler@stonybrookmedicine.edu.
Abstract
BACKGROUND: The prevalence of heart failure is expected to significantly rise unless high-risk patients are effectively screened and appropriate, cost-effective prevention interventions are implemented. METHODS AND RESULTS: We performed a systematic review to evaluate the prediction characteristics of the published heart failure risk prediction models as of August 2014 using MEDLINE and EMBASE databases. Eligible studies reported the development, validation, or impact assessment of a model. Two investigators performed independent review to extract data on study design and characteristics, risk predictors, discrimination, calibration, and reclassification ability of models, as well as validation and impact analysis. We included 13 publications reporting on 28 heart failure risk prediction models. Models had acceptable-to-good discriminatory ability (c-statistics, >0.70) in the derivation sample. Calibration was less commonly assessed, but was acceptable when it was. Only 2 models were externally validated more than once, displaying modest-to-acceptable discrimination (c-statistics, 0.61-0.79). When assessed, novel blood and imaging markers modestly improved risk prediction. One model assessed the prediction properties in race-based subgroups, whereas 2 models evaluated sex-based subgroups. Impact analysis found none of the models recommended for use in any clinical practice guideline. CONCLUSIONS: Incident heart failure risk prediction remains at an early stage. The discrimination ability of current models is acceptable in derivation data sets but most models have not been externally validated. It remains unclear which models are cost-effective and best suit population screening needs. The effects of models on clinical and preventative care requires further study.
BACKGROUND: The prevalence of heart failure is expected to significantly rise unless high-risk patients are effectively screened and appropriate, cost-effective prevention interventions are implemented. METHODS AND RESULTS: We performed a systematic review to evaluate the prediction characteristics of the published heart failure risk prediction models as of August 2014 using MEDLINE and EMBASE databases. Eligible studies reported the development, validation, or impact assessment of a model. Two investigators performed independent review to extract data on study design and characteristics, risk predictors, discrimination, calibration, and reclassification ability of models, as well as validation and impact analysis. We included 13 publications reporting on 28 heart failure risk prediction models. Models had acceptable-to-good discriminatory ability (c-statistics, >0.70) in the derivation sample. Calibration was less commonly assessed, but was acceptable when it was. Only 2 models were externally validated more than once, displaying modest-to-acceptable discrimination (c-statistics, 0.61-0.79). When assessed, novel blood and imaging markers modestly improved risk prediction. One model assessed the prediction properties in race-based subgroups, whereas 2 models evaluated sex-based subgroups. Impact analysis found none of the models recommended for use in any clinical practice guideline. CONCLUSIONS: Incident heart failure risk prediction remains at an early stage. The discrimination ability of current models is acceptable in derivation data sets but most models have not been externally validated. It remains unclear which models are cost-effective and best suit population screening needs. The effects of models on clinical and preventative care requires further study.
Authors: Kuo Zhang; Wenyao Wang; Shihua Zhao; Stuart D Katz; Giorgio Iervasi; A Martin Gerdes; Yi-Da Tang Journal: Clin Cardiol Date: 2018-01-23 Impact factor: 2.882
Authors: Rudolf A de Boer; Matthew Nayor; Christopher R deFilippi; Danielle Enserro; Vijeta Bhambhani; Jorge R Kizer; Michael J Blaha; Frank P Brouwers; Mary Cushman; Joao A C Lima; Hossein Bahrami; Pim van der Harst; Thomas J Wang; Ron T Gansevoort; Caroline S Fox; Hanna K Gaggin; Willem J Kop; Kiang Liu; Ramachandran S Vasan; Bruce M Psaty; Douglas S Lee; Hans L Hillege; Traci M Bartz; Emelia J Benjamin; Cheeling Chan; Matthew Allison; Julius M Gardin; James L Januzzi; Sanjiv J Shah; Daniel Levy; David M Herrington; Martin G Larson; Wiek H van Gilst; John S Gottdiener; Alain G Bertoni; Jennifer E Ho Journal: JAMA Cardiol Date: 2018-03-01 Impact factor: 14.676
Authors: Toshiaki Ohkuma; Min Jun; Mark Woodward; Sophia Zoungas; Mark E Cooper; Diederick E Grobbee; Pavel Hamet; Giuseppe Mancia; Bryan Williams; Paul Welsh; Naveed Sattar; Jonathan E Shaw; Kazem Rahimi; John Chalmers Journal: Diabetes Care Date: 2017-07-06 Impact factor: 19.112
Authors: Sadiya S Khan; Hongyan Ning; Sanjiv J Shah; Clyde W Yancy; Mercedes Carnethon; Jarett D Berry; Robert J Mentz; Emily O'Brien; Adolfo Correa; Navin Suthahar; Rudolf A de Boer; John T Wilkins; Donald M Lloyd-Jones Journal: J Am Coll Cardiol Date: 2019-05-21 Impact factor: 24.094
Authors: Vaiibhav N Patel; Brian R Pierce; Rohan K Bodapati; David L Brown; Diane G Ives; Phyllis K Stein Journal: JACC Heart Fail Date: 2017-04-05 Impact factor: 12.035
Authors: Lindsey Aurora; Edward Peterson; Hongsheng Gui; Nicole Zeld; James McCord; Yigal Pinto; Bernard Cook; Hani N Sabbah; L Keoki Williams; James Snider; David E Lanfear Journal: Clin Chim Acta Date: 2020-09-12 Impact factor: 3.786
Authors: Jennifer E Ho; Danielle Enserro; Frank P Brouwers; Jorge R Kizer; Sanjiv J Shah; Bruce M Psaty; Traci M Bartz; Rajalakshmi Santhanakrishnan; Douglas S Lee; Cheeling Chan; Kiang Liu; Michael J Blaha; Hans L Hillege; Pim van der Harst; Wiek H van Gilst; Willem J Kop; Ron T Gansevoort; Ramachandran S Vasan; Julius M Gardin; Daniel Levy; John S Gottdiener; Rudolf A de Boer; Martin G Larson Journal: Circ Heart Fail Date: 2016-06 Impact factor: 8.790